achievements 2018
Join BNMS | Print Page | Contact Us | Sign In
BNMS Achievements last year
BNMS Achievements
In 2024:

We want to thank you for your continued support. Your membership has allowed us to achieve so much this year. In 2024 BNMS has been remarkably busy:

  • Two successful conferences, one in Norwich (Autumn meeting) and the other in Belfast (Spring meeting). Attendance for these continues to grow and feedback for both was extremely positive – even for the food!
  • Study days in the Online Education Series with Royal Free Nuclear Medicine Academy
  • We have been looking at member benefits, and as part of this have introduced the following:
    • We launched a series of Webinars on different aspects of research. Although the live events were open to all, access to the recordings is a BNMS members’ benefit.
    • We introduced a members event the evening before the start of the Spring meeting, to allow networking with speakers and refreshments. Note: non-members can attend with an extra charge.
  • IPEM and the BNMS are working together to address the issue of the lack of statutory registration for Clinical Technologists, including Nuclear Medicine Technologists. This year has seen significant progress, with successful engagement of the National Guardian and the support of the UKHSA.
  • Following on from the merger of the UK MRT Consortium and the BNMS MRT Group, the newly formed BNMS MRT Consortium has made excellent progress with its initial action plan, solidly establishing this group as a key stakeholder in MRT. A face-to-face event has been organised in London for January this year to review the action plan and develop a roadmap for MRT services in the UK. BNMS has written to the Health Secretary to seek his support for this work.
  • A workforce task force has been set up in response to the BNMS membership survey, with representation from the different professional groups who will be developing an action plan and reporting back regularly to Council and to members. Progress will be fed back to members.
  • Together with our Nuclear Medicine community, BNMS worked closely with the DHSC, NHSE and its equivalent in the devolved nations to manage the recent significant shortage in Molybdenum availability.

Molybdenum Supply Response

BNMS President Jilly Croasdale coordinated the BNMS response to a significant shortage in Molybdenum availability, caused by problems with both the BR2 reactor in Belgium and the HFR reactor in Holland, exacerbated by required shutdowns for maintenance and refuelling at the Maria Reactor on Poland, in order to minimise the impact on patients who urgently needed nuclear medicine scans. BNMS worked with the UK Radiopharmacy Group, the DHSC, NHS England and the devolved nations to establish a system of mutual aid across the UK. This reduced the potential impact the huge gap in supply could have had in many parts of the country. The plan prioritised patients according to clinical need and redistributed available activity to ensure all regions had some access to a supply of the most urgently needed tracers. Jilly Croasdale made regular communications on behalf of BNMS to the Nuclear Medicine community to try to ensure everyone knew what was happening, regardless of membership.

Current Guidelines

Scientific Support for Nuclear Medicine

The Provision of Radionuclide Diagnostic Services

Guidance on Staffing

Consent Issues in Nuclear Medicine

Provision of Paediatric Radionuclide

Imaging Services Clinical Guideline for the measurement of glomerular filtration rate(GFR) using plasma sampling

Lacrimal scintigraphy BNMS Guidelines

Administration of Molecular Radiotherapy

Dynamic Renal

Radionuclide Studies (Renography)

Lymphoscintigraphy

Gastric emptying

Recommendations for good clinical practice for DPD bone scintigraphy for cardiac amyloidosis

Radionuclide Cardiac Ventriculogram for the Assessment of Left Ventricular Systolic Function

Clinical Guideline for Parathyroid Scintigraphy

Certificate of Competence in the Administration of Intravenous Radiopharmaceuticals

BNMS Procedure Guidelines for Radionuclide Lymphoscintigraphy for Sentinel Node Localisation in Breast Carcinoma

BNMS Procedure Guidelines for Bone Scintigraphy

BNMS UK PET standards

UKRG Guidance for Radiopharmacies during the Covid-19 Pandemic

Capacity Planning Guidance

Key Performance Indicators (KPIs) in Radiopharmacy

The Responsibilities of Chief Pharmacists for Radiopharmaceuticals

Addendum to Safe Drawing up document for 223Ra Radium

Guidance for Introduction of a 68Ge/68Ga Generator and Labelling Service into Routine Clinical Practice

Guidance on the Recapping of Needles in Radiopharmacy and Nuclear Medicine

Safe drawing up of radiopharmaceuticals in nuclear medicine departments

QUALITY ASSURANCE OF RADIOPHARMACEUTICALS

Guidelines for the provision of radiopharmacy services in the UK

Guidance on the transfer of Tc-99m generator eluates and sharing of Mo-99/Tc-99m generators between different Hospitals

Discontinued products

Guidelines for the safe preparation of radiolabelled blood cells

ICD10 Diagnostic Codes

Clinical Indications codes

BNMS PET-CT Tracer Commissioning Manifesto

Criteria for the establishment of a pediatric PET-CT centre (UKPETCT Advisory Board)

PET-CT in the UK

Thyroid Guidelines

IDUG Guideline - Whole body dosimetry guidance

ATA Guidelines for Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum

RCR Guideline - Guidelines for the use of PET-CT in children

Low Iodine Diet : Revision of the patient information developed by the UK Low Iodine Diet Working Group

Office for Nuclear Regulation Transport Guidelines

Use of somatostatin analogue-based PRRNT

IAEA - Good Practice for Introducing Radiopharmaceuticals for Clinical Use

The Science of Casemix

Evidence Based Indications for the use of PETCT in the UK

Notes for Guidance on the clinical Administration of Radiopharmaceuticals (ARSAC)

IPEM Guideline : Advice note on in-house software for Nuclear Medicine

BTS Guidelines for the Investigation and Management of Pulmonary Nodules

Lifelong learning and building teams using peer feedback

Procedure Guidelines for Radionuclide Myocardial Perfusion Imaging with Single-Photon Emission Computed Tomography (SPECT)

ATA Treatment of Hypothyroidism Guideline - American Thyroid Association

Molecular Radiotherapy: Guidance for Clinicians

British Thyroid Association Guidelines for the Management of Thyroid Cancer

Myocardial Perfusion Scintigraphy: The Evidence (BNCS) – BMJ

Adjustment of administered Activity for Paediatrics

IPEM Recommendations for Clinical Scientist Support for PETCT

Environmental Permitting Regulations 2010 and Guidance

Inclusive pregnancy status guidelines for ionising radiation: Diagnostic and therapeutic exposures

Evidence-based indications for the use of PET-CT in the United Kingdom 2022

UKHSA: User guidance and national coding taxonomy for incident learning in clinical imaging, magnetic resonance imaging and nuclear medicine

Paediatric DMSA Guidelines (NEW in 2024)

Inclusivity Guidance (NEW in 2024)

UK PET Standards (NEW in 2024)

Guidelines in development

VQ scan guidelines in Pulmonary Hypertension

Platelet Survival

Guidelines for the provision of Technologist support

Guidelines under review

Gamma Camera Tender Documents

Hepatobiliary Scintigraphy

Measurement of Glomerular Filtration Rate using Plasma Sampling (GFR)

We held two successful scientific meetings with excellent feedback from delegates on their content and usefulness:

BNMS Spring Annual Meeting 2024 – May 2024 at ICC, Belfast - Attendance 505 delegates

BNMS Autumn Meeting 2024 – The Assembly House and The Forum, Norwich – October 2024 - Attendance 139 delegates

BNMS and the Royal Free Nuclear Medicine Academy jointly held the SPECT-CT Study Day online lead by Dr Arum Parthipun.

BNMS launched the BNMS Research Webinar Series, talks include:
12th November 2024 - Prof Gary Cook, Navigating the Regulatory Requirements to Imaging Research
10th December 2024 - Dr Maggie Cooper, The challenges of producing radiopharmaceuticals for research trials
Another five monthly webinars are scheduled until May 2025

The BNMS has responded to these consultations:

NHS Payment Scheme consultation

WHSSC Consultation: CP50a - PET Commissioning Policy

HBN 06-01 Facilities for diagnostic imaging and interventional radiology (2024 draft)

The Future Nuclear Medicine Workforce: EANM Survey to the National Societies.

Consultation: specialised amyloidosis services

NMGI at SNMMI document on nomenclature

Joint EANM, IAEA, and SNMMI practical guidance on somatostatin receptor-targeted radionuclide therapy of neuroendocrine tumours

Young Sections of EANM National Societies

We conducted the 2024 round of the BNMS membership survey. Jilly Croasdale provided some initial feedback on this in her monthly blog.
View the results of the BNMS membership survey here

Awards were presented as follows:

President's Medal, Dr John Buscombe, Cambridge University Hospitals Trust

BNMS Roll of Honour, Dr Bev Ellis, Manchester University NHS Foundation Trust

Norman Veall Medal, Dr Glenn Flux, Royal Marsden Hospital

Radiographers, Technologists & Nurses Group Award, Prof Emeritus Peter Hogg, University of Salford

Honorary Membership, Mr Stephen Anderson, previously of Bright Technologies

These awards were presented at the BNMS Annual Meeting held in Belfast in May 2024

BNMS representatives’ sit on the following committees:

The Academy for Healthcare Science Professions Bodies Council

APPG for Diagnostics

BNCS rep on Council

BTS Pulmonary nodule guideline

NHS England Cancer Diagnosis Clinical Reference Group

Committee for Liaison with International Partner Societies (CLIPS) hosted by The Society for Radiological Protection

CPD committee of the Federation of the Royal Colleges of Physicians

EANM national Delegates

EANM Radiopharmacy Committee

RCP Expert Advisory Group on Commissioning

Imaging and Oncology Forum

RCP/RCR Intercollegiate Standing Committee on Nuclear Medicine

IPEM Clinical Technologists Action Group

IPEM Nuclear Medicine Special Interest Group

RCP JSC Nuclear Medicine

London Nuclear Medicine Workforce Group

MITHRAS advisory board

Molecular Radiotherapy Clinical Reference Group

National School of Healthcare Science Physical Sciences Themed Board

NIHR

NCRI Clinical and Translational Radiotherapy Research Working Group

NHS Digital (pka Health and Social Care Information Centre)

BIR Nuclear Medicine and Molecular Imaging Committee

PET-CT Commissioning Manifesto Group

British Thoracic Society Quality Standards Group

NHSE Radiotherapy Learning Healthcare System

RCP Medical Care - Driving Change Portal

RCR Radionuclide advisor

RCR SIGs Committee

RCP Revalidation Specialty Adviser

SCoR Nuclear Medicine and Molecular Imaging Advisory Group

Environment Agency Small User Liaison Group

Joint Royal Colleges of Physicians Training Board Specialist Advisory Committee in Nuclear Medicine

Staffing in Imaging Group

Medical Radioisotope and Research Reactor (MRRR) Programme Phase 3 Steering Group

Nuclear Medicine of the European Union of Medical Specialists and European board of Nuclear Medicine (UEMS and EBNM)

TAC

UKAS Medical Physics and Clinical Engineering (MPACE) Committee who are introducing a national accreditation scheme for medical physics

WFNMB

We were invited by ARSAC to submit evidence via the UKHSA to the DHSC on the need for statutory registration of Clinical Technologists.

BNMS has written to Wes Streeting, Secretary of State for Health, to ask for his help in responding to the anticipated increase in demand on Nuclear Medicine in supporting expanding MRT and theranostic services.

 

 

© 2013 BNMS unless otherwise stated.
The BNMS is a registered as a company in England and Wales with number 08082786.  The BNMS is a charity governed by the rules of the Charity Commission for England and Wales - Registered Number 1150234.  Registered Office: The Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London NW1 4LE.
The British Nuclear Medicine Society is not able to give specific clinical advice to members of the public. If you are concerned about your scan or therapy please seek the opinion of a nuclear medicine clinician where you were seen or the clinician who referred you to the department or your GP.
Enquiries related to issues such as internships and work experience opportunities, should be directed to the relevant professional body e.g., for radiologists, this will be the Royal College of Radiologists.